Shukra Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524632

₹245.80 image4.80 (1.99 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 245.80

High (₹) 245.80

Low (₹) 245.80

Prev. Close (₹) 241.00

Volume 8,553

VWAP (₹) 230.64

ROCE (%) 31.66

Industry P/E 43.95

TTM P/E 131.44

P/B Ratio 4.67

Market Cap (₹) Cr.1,076.31

Dividend Yield (%)0.41

EPS (₹) 16.93

ROE32.16%

Sales Growth (%) 26.75

Profit Growth (%)320.68

Day Range

245.80245.80

L
H

52 Week Range

57.52271.50

L
H

Historical Returns

Returns (6M)

285.93 %

Returns (1Y)

261.58 %

Returns (3Y)

7371.12 %

Returns (5Y)

9973.77 %

Returns (6M)

285.93 %

Returns (1Y)

261.58 %

Returns (3Y)

7371.12 %

Returns (5Y)

9973.77 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Positive ROC (9) indicates upward momentum.
  • Price above the pivot point indicates bullish sentiment.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 66.07

MFI 86.83

ATR 7.96

Commodity Channel Index 76.22

ROC125 263.05

ROC21 0.64

Williams %R -0.29

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current242.50250.00264.85227.65220.15205.30197.80
Week Ago193.55193.55193.55193.55193.55193.55193.55
Month Ago224.50224.50224.50224.50224.50224.50224.50

EMA & SMA
info_icon

245.80

Current Price

EMA & SMApin

Bullish Moving Averages

20

Bearish Moving Averages

0

5 Day 207.06


9 Day 207.29


10 Day 207.99


12 Day 211.25


14 Day 210.93

20 Day 217.69


26 Day 219.29


50 Day 186.37


100 Day 127.76


200 Day 108.00

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

No insider trading details available.

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
29 Jan, 2025Stock split from Rs. 10/- to Re. 1/-.21 Mar, 202521 Mar, 2025
29 May, 2024Rs.1.0000 per share(10%)Final Dividend23 Sept, 202401 Jan, 1970
29 Feb, 2024Bonus issue in the ratio of 3:1 of Rs. 10/-.19 Apr, 202420 Apr, 2024
29 May, 2023Rs.0.5000 per share(5%)Final Dividend15 Sept, 202301 Jan, 1970
25 Aug, 2022Rights issue of equity shares of Rs. 10/- in the ratio of 6:1 @ premium of Rs. 10/-.02 Feb, 202302 Feb, 2023
30 May, 2022Rs.0.5000 per share(5%)Final Dividend22 Sept, 202201 Jan, 1970

Announcements

DateSourceDetail
07 Mar, 2025BSE IndiaThis is to inform you that Friday, 21st March, 2025 has been fixed as the Record Date.
07 Mar, 2025BSE IndiaVoting result of Postal Ballot under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
14 Feb, 2025BSE IndiaSubmission Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31st December, 2024
14 Feb, 2025BSE IndiaConsidered and approved Un-audited Financial Results of the Company along with Limited Review Report for the quarter and Nine Months ended on 31st December, 2024.
14 Feb, 2025BSE IndiaOutcome of Board Meeting held today i.e. on 14th February, 2025 and 1. submission of Un-audited Financial Results of the Company for the Quarter and Nine months ended on 31st December, 2024.\r\n2. Appointment Mr. Jay Gandhi, as Internal Auditor for FY 2024-25, The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is attached as 'Annexure A'.\r\n3. Appointment of Ms. Shilpa Shah (Practising Company Secretary), as Secretarial Auditor for FY 2024-25, The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is attached as 'Annexure B'.
04 Feb, 2025BSE IndiaSubmission of Notice of the Postal Ballot pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
03 Feb, 2025BSE IndiaShukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve The Un-audited Financial Results of the Company, for the Third quarter and Nine months ended on 31st December, 2024 of the current financial year 2024-25, pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
29 Jan, 2025BSE IndiaOutcome of Board Meeting held today i.e. on January 29, 2025 pursuant to Regulation 30 of SEBI (Listing and Obligations and Disclosure Requirements) Regulations, 2015
24 Jan, 2025BSE IndiaShukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 ,inter alia, to consider and approve Subdivision/ Stock Split of Equity Shares of the Company, subject to approval of the shareholders the Company and other necessary approvals
04 Jan, 2025BSE IndiaShukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2025 ,inter alia, to consider and approve To offer and issue of equity shares of the Company by way of a rights issue to eligible shareholders of the Company as on the record date (to be decided at a later date) for an amount not exceeding ? 36 crore in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws (the \Rights Issue\).

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--04 Feb, 202514 Feb, 2025
Stock Split--25 Jan, 202529 Jan, 2025
Others--06 Jan, 202509 Jan, 2025
Quarterly Results--08 Nov, 202414 Nov, 2024
Rights issue of Equity Shares--25 Sept, 202428 Sept, 2024
Quarterly Results--06 Aug, 202412 Aug, 2024
Audited Results & Dividend--22 May, 202429 May, 2024
Quarterly Results--06 Feb, 202412 Feb, 2024
Quarterly Results--30 Oct, 202308 Nov, 2023
Quarterly Results--07 Aug, 202312 Aug, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Shukra Pharmaceuticals

Shukra Pharmaceuticals is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 74.57 Cr. and Equity Capital is Rs. 10.95 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1993

Managing Director

Mr. Dakshesh Rameshchandra Shah

NSE Symbol

--

Shukra Pharmaceuticals Management

NameDesignation
Mr. Dakshesh Rameshchandra ShahManaging Director
Mrs. Payal Sujay MehtaExecutive Director
Mr. Dhruvin ShahWhole Time Director
Mr. Sanskruti Jayeshbhai PatelWhole Time Director
Mrs. Anar Jayeshbhai PatelWhole Time Director
Mrs. Bhoomiben PatelIndependent Director
Mrs. Sonal Deepalbhai GandhiIndependent Director
Mr. Sarjeevan Singh RathoreIndependent Director
Mr. Jitendra Somchand ShahIndependent Director
Mrs. Pinki Nirmal SagarIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Shukra Pharmaceuticals

What is the share price of Shukra Pharmaceuticals?

The share price of Shukra Pharmaceuticals on 13 Mar, 2025 is ₹ 245.80.

What is 52W high and 52W low share price of Shukra Pharmaceuticals?

The highest and lowest 52W share prices of Shukra Pharmaceuticals are ₹ 271.500 and ₹ 57.520

What is the market cap of Shukra Pharmaceuticals?

The market capitalization of Shukra Pharmaceuticals as of 13 Mar, 2025 is ₹ 1,076.31 Crores

What is the P/E ratio of Shukra Pharmaceuticals?

The current P/E ratio of Shukra Pharmaceuticals as of 13 Mar, 2025 is 43.95

What is the PB ratio of Shukra Pharmaceuticals?

The PB ratio of Shukra Pharmaceuticals as of 13 Mar, 2025 is 4.67

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited